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MicroRNAs (miRNAs) are approximately 22-nucleotide-
long  non-coding  RNA  molecules  that  were  first 
discovered in Caenorhabditis elegans but are now known 
to  be  expressed  in  all  metazoans.  miRNA  genes  are 
present singly or in clusters, often with their individual 
promoters and regulatory elements, while some miRNA 
genes are also present within the introns of other protein 
coding genes. miRNAs are transcribed as long primary 
transcripts and are processed first in the nucleus by the 
microprocessor  DRSH-1/DROSHA  and  then  in  the 
cytoplasm by the DCR-1/DICER complex to generate the 
active  21  to  23-nucleotide  RNA  molecules.  These  are 
recruited by the RNA-induced silencing complex (RISC) 
and  guided  to  the  3’  untranslated  regions  of  target 
messenger RNAs (mRNAs) with complete or incomplete 
sequence  complementarity,  resulting  in  either 
degradation  of  the  target  mRNA  or  inhibition  of  its 
translation. A single miRNA can target multiple mRNAs 
and  this  ability  to  control  the  expression  of  numerous 
genes  makes  miRNAs  pivotal  in  regulating  various  life 
processes,  from  development  through  metabolism  to 
senescence, aging and death (reviewed in [1]).
While  animals  like  C.  elegans  contain  hundreds  of 
miRNAs, little is known about their functions. Moreover, 
with  the  advent  of  deep  sequencing  technology,  novel 
miRNAs  are  being  discovered  in  different  model 
organisms,  requiring  faster  and  more  convenient 
methodologies  to  study  their  functional  importance 
through inhibiting their activity in vivo. A recent report 
by  Zheng  and  colleagues  [2]  now  demonstrates  the 
efficient and specific inhibition of miRNAs in C. elegans by 
dextran-conjugated modified antisense oligonucleotides.
miRNAs were first identified in C. elegans in 1993 [3] 
and  since  then  this  elegant  model  system  has  been 
extensively utilized for functional analysis of miRNAs. C. 
elegans is so useful for these analyses because of its easy 
genetics,  completely  sequenced  genome  and  simple 
anatomy.  To  study  the  role  of  individual  miRNAs  in 
different cellular pathways, forward genetics approaches 
have yielded many ‘loss of function’ (lf) mutant strains 
for various miRNAs [4,5]. Although such mutant strains 
have been extensively used for functional studies of the 
target miRNAs, their generation is both time consuming 
and  labor  intensive.  Further,  it  is  tedious  to  generate 
knockout  alleles  for  miRNAs  that  are  essential  for 
survival  and  development,  and  in  cases  where  the 
miRNAs are located in the intronic sequences of protein 
coding  genes,  it  is  possible  that  their  knockout  will 
perturb expression of the protein coding gene. It is also 
difficult to specifically knock out a single miRNA from a 
miRNA gene cluster without affecting the expression of 
the remaining miRNAs in the cluster.
Many  groups  have  tried  using  reverse  genetics 
approaches  to  inhibit  specific  miRNA  function 
transiently in different model systems. The most popular 
tool  of  choice  is  differently  modified  antisense 
oligonucleotides,  which  are  easy  to  synthesize  and 
deliver.  Several  research  groups  have  demonstrated 
inhibition of miRNA function with limited success using 
antisense oligonucleotides such as locked nucleic acids 
(modified RNA nucleotides) [6] or morpholinos (nucleic 
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[8-10].
C. elegans has been widely used as the model system to 
study the biological role of small non-coding RNAs and 
yet,  to  date,  no  standard  techniques  or  protocols  are 
available  to  effectively  and  conveniently  knockdown 
miRNA  function  transiently.  To  inhibit  miRNA 
expression in C. elegans, Zamore’s group injected 2’-oxy-
methyl  oligonucleotides  into  developing  embryos  [11]. 
Their embryo injection technique is technically difficult 
and,  therefore,  has  not  been  used  extensively. 
Furthermore,  the  primary  drawback  of  using  these 
modified  oligonucleotides  is  the  incumbent  toxicity 
caused  by  poor  solubility  and  inadequate  cytoplasmic 
retention and tissue distribution.
To  address  these  issues,  Zheng  and  colleagues  [2] 
conjugated  2’-oxy-methyl  antisense  oligonucleotides 
complementary  to  the  target  miRNAs  with  the 
polysaccharide  dextran,  which  has  high  solubility  in 
water  and  shows  increased  cellular  uptake  and 
availability.  The  authors  also  modified  these 
oligonucleotides by conjugating one to three molecules 
of rhodamine per molecule of dextran. These modified 
antisense  oligonucleotides  were  injected  into  the 
syncytial  gonads  of  adult  worms  and  embryos  were 
selected based on the presence of rhodamine (Figure 1).
Zheng  and  colleagues  [2]  used  antisense 
oligonucleotides  complementary  to  lin-4  and  let-7  and 
comprehensively  demonstrated  robust  knockout 
phenotypes similar to those seen in the respective loss of 
function mutant strains of lin-4 and let-7. For example, 
progeny  of  animals  injected  with  antisense 
oligonucleotides  against  lin-4  show  delayed  exit  in 
differentiation of seam cells and lack of vulva formation, 
known  phenotypes  for  lin-4(lf)  [3].  The  progeny  of 
worms  injected  with  antisense  oligonucleotides 
complementary  to let-7  demonstrated  a  bursting vulva 
phenotype  with  lack  of  alae  (longitudinal  ridge) 
formation  in  100%  of  animals,  consistent  with  the 
phenotype shown by let-7 knockout mutant animals [5]. 
By contrast, progeny of animals treated with antisense 
oligonucleotides complementary to miR-84, a let-7 family 
member, exhibited no visible phenotype, consistent with 
the known phenotype of mir-84(lf) mutants. miR-84 has 
a sequence that is highly homologous to let-7 sequence, 
yet the phenotype observed in the miR-84 knockdown 
animals  was  completely  unlike  the  let-7  knockdown 
phenotype  therefore  confirming  the  specificity  of 
inhibition.  Using  a  similar  strategy,  the  authors  could 
demonstrate  specific  inhibition  of  lys-6  miRNA  in  the 
ASEL neurons, where it functions to maintain left-right 
symmetry. This technique also successfully demonstrated 
the inhibition in activity of miR-42, which is active only 
during embryonic development. In addition, the authors 
demonstrate  that  this  new  class  of  antisense 
oligonucleotides  could  be  utilized  for  specific  and 
simultaneous inhibition of two miRNAs, in this case lin-4 
and lys-6.
As  with  all  antisense  techniques,  the  dextran-
conjugated  antisense  2’-oxy-methyl  oligonucleotides 
have a limitation, in this case with respect to the period 
of  efficacy  of  inhibition  against  target  miRNAs  in  the 
animal. The inhibition was robust until 15-20 hours after 
the L4 molt with higher doses of injection, after which 
the effect diminished, most probably due to the dilution 
of the antisense oligonucleotides inside the animal. For 
this reason this method of miRNA inhibition might not 
be  the  most  effective  for  long-term  functional  assays, 
such as aging assays, where the miRNA in question needs 
to be inhibited throughout the life span of the animal.
Overall, the data presented in the report by Zheng and 
colleagues [2] convincingly suggest that this new class of 
antisense  oligonucleotides  could  prove  to  be  a  very 
powerful  and  effective  tool  for  the  robust  and  specific 
inhibition  of  miRNA  function  in  vivo.  This  technique 
would be very useful for studying the different biological 
functions of essential and novel miRNAs in C. elegans. 
While it remains to be tested, this technology does not 
appear  to  be  limited  to  just  C.  elegans,  and  could  be 
applicable in other organisms as well.
Figure 1. Schematic representation of the technique elaborated 
in the study by Zheng and colleagues. In this technique, a 
dextran-conjugated rhodamine-labeled antisense oligonucleotide 
complementary to the target microRNA is injected into the syncytial 
gonads of C. elegans. The transformed progeny are selected 
by the presence of rhodamine. In these progeny the antisense 
oligonucleotides bind to and deplete the available pool of target 
miRNA, thus inhibiting miRNA function in the animal.
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